Richard E Lowenthal sold $1.4M of ARS Pharmaceuticals (SPRY)

Executed Nov 19 2024, disclosed Nov 21 2024, 2 days later.

Value, as filed

$1.4M

100,000 sh across 2 lots

Executed

Nov 19 2024

the trade date, as filed

Disclosed

Nov 21 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RL Richard E Lowenthal PRESIDENT AND CEO profile →

Richard E Lowenthal (PRESIDENT AND CEO) filed 7 Form 4 reports in the past 24 months (0 purchases, 7 sales), most often in SPRY. The largest single filing was $1.5M of SPRY (90,169 sh across 2 lots, as filed), executed Nov 12 2024.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Richard E Lowenthal in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $724K
50,000 sh × $14.49
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.2M
100,000 sh across 2 lots
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.3M
100,000 sh across 2 lots
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.5M
90,169 sh across 2 lots
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.5M
98,550 sh across 2 lots
Exec Oct 15 2024
Filed Oct 17 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.4M
100,000 sh across 2 lots
Exec Oct 8 2024
Filed Oct 10 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.3M
100,000 sh across 2 lots
Exec Sep 17 2024
Filed Sep 19 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.1M
100,000 sh across 2 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET